+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Renal Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 143 Pages
  • April 2022
  • Region: Global
  • IMARC Group
  • ID: 5578102
The global renal biomarkers market reached a value of US$ 1.13 billion in 2021. Looking forward, the market is projected to reach a value of US$ 1.88 billion by 2027, exhibiting a CAGR of 8.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different End-use sectors. These insights are included in the report as a major market contributor.



Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a urinalysis. They assist in determining the glomerular filtration rate (GFR) of kidneys to analyze their proper functioning and evaluating pathogenic processes or pharmacological responses to therapeutic interventions. As they also aid in predicting disease progression and computing drug dosage, renal biomarkers find extensive applications in hospitals and diagnostic laboratories across the globe.

Renal Biomarkers Market Trends


Chronic kidney disease (CKD), non-communicable disease with considerable morbidity and mortality, has gradually become a public health concern globally and its main risk factors are diabetes, hypertension and heart diseases. The increasing number of individuals with CKD represents one of the key factors propelling the growth of the market. Moreover, renal biomarkers, including blood urea nitrogen (BUN), serum creatinine (SCr), urinary albumin/protein and volume excretion, are used in the diagnosis of chronic kidney disease (CKD) and monitoring of the disease. Besides this, there is a growing interest of industry investors in novel single biomarkers and process-specific biomarker panels in human renal diseases around the world. These novel biomarkers provide vital diagnostic and prognostic information and help predict response to the treatment of glomerulopathies, acute kidney injury (AKI), and autosomal dominant polycystic kidney disease (ADPKD). Apart from this, renal biomarkers are becoming accessible and feasible in all-sized laboratories. This, along with the development and integration of genomics, epigenetics, transcriptomics, proteomics, and metabolomics, is positively influencing the market. Some of the other factors, such as the burgeoning healthcare industry, the rising geriatric population, and the increasing number of clinical trials for CKD worldwide, are anticipated to facilitate the growth of the market.

Key Market Segmentation


This report provides an analysis of the key trends in each sub-segment of the global renal biomarkers market, along with forecasts at the global, regional and country level from 2022-2027. The report has categorized the market based on biomarker type, diagnostic technique and End-user.

Breakup by Biomarker Type:

  • Functional Biomarker
  • Serum Creatinine
  • Serum Cystatin C
  • Urine Albumin
  • Up-regulated Protein
  • Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  • Kidney Injury Molecule-1
  • INTERLEUKIN-18
  • Others

Breakup by Diagnostic Technique:

  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Particle-enhanced Turbidimetric Immunoassay (PETIA)
  • Colorimetric Assay
  • Chemiluminescent Enzyme Immunoassay (CLIA)
  • Liquid Chromatography Mass Spectrometry (LC-MS)

Breakup by End-user:

  • Hospital
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape


The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A/S, Bio-Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann-La Roche AG, PerkinElmer Inc., Randox Laboratories Ltd., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • How has the global renal biomarkers market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global renal biomarkers market?
  • What are the key regional markets?
  • What is the breakup of the market based on the biomarker type?
  • What is the breakup of the market based on the diagnostic technique?
  • What is the breakup of the market based on the End-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global renal biomarkers market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Renal Biomarkers Market

What is the estimated value of the Global Renal Biomarkers Market?

The Global Renal Biomarkers Market was estimated to be valued at $1.1 Billion in 2021.

What is the growth rate of the Global Renal Biomarkers Market?

The growth rate of the Global Renal Biomarkers Market is 8.8%, with an estimated value of $1.9 Billion by 2027.

What is the forecasted size of the Global Renal Biomarkers Market?

The Global Renal Biomarkers Market is estimated to be worth $1.9 Billion by 2027.

Who are the key companies in the Global Renal Biomarkers Market?

Key companies in the Global Renal Biomarkers Market include Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), bioMérieux SA, BioPorto A/S, Bio, Rad Laboratories Inc., Enzo Biochem Inc., F. Hoffmann and PerkinElmer Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Renal Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Biomarker Type
6.1 Functional Biomarker
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Serum Creatinine
6.1.2.2 Serum Cystatin C
6.1.2.3 Urine Albumin
6.1.3 Market Forecast
6.2 Up-regulated Protein
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Neutrophil Gelatinase-Associated Lipocalin (NGAL)
6.2.2.2 Kidney Injury Molecule-1
6.2.2.3 INTERLEUKIN-18
6.2.3 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Diagnostic Technique
7.1 Enzyme-linked Immunosorbent Assay (ELISA)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Particle-enhanced Turbidimetric Immunoassay (PETIA)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Colorimetric Assay
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Chemiluminescent Immunoassay (CLIA)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Liquid Chromatography Mass Spectrometry (LC-MS)
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospital
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Laboratory
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Beckman Coulter Inc. (Danaher Corporation)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 bioMérieux SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 BioPorto A/S
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Bio-Rad Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Enzo Biochem Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 F. Hoffmann-La Roche AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 PerkinElmer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Randox Laboratories Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Siemens AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Renal Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Renal Biomarkers Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Renal Biomarkers Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Renal Biomarkers Market: Breakup by Biomarker Type (in %), 2021
Figure 5: Global: Renal Biomarkers Market: Breakup by Diagnostic Technique (in %), 2021
Figure 6: Global: Renal Biomarkers Market: Breakup by End User (in %), 2021
Figure 7: Global: Renal Biomarkers Market: Breakup by Region (in %), 2021
Figure 8: Global: Renal Biomarkers (Functional Biomarker) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Renal Biomarkers (Functional Biomarker) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Renal Biomarkers (Up-regulated Protein) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Renal Biomarkers (Up-regulated Protein) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Renal Biomarkers (Other Biomarker Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Renal Biomarkers (Other Biomarker Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Renal Biomarkers (Enzyme-linked Immunosorbent Assay (ELISA)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Renal Biomarkers (Particle-enhanced Turbidimetric Immunoassay (PETIA)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Renal Biomarkers (Colorimetric Assay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Renal Biomarkers (Colorimetric Assay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Renal Biomarkers (Chemiluminescent Immunoassay (CLIA)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Renal Biomarkers (Liquid Chromatography Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Renal Biomarkers (Hospital) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Renal Biomarkers (Hospital) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Renal Biomarkers (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Renal Biomarkers (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Renal Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Renal Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Renal Biomarkers Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Renal Biomarkers Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Renal Biomarkers Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Renal Biomarkers Industry: SWOT Analysis
Figure 80: Global: Renal Biomarkers Industry: Value Chain Analysis
Figure 81: Global: Renal Biomarkers Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Renal Biomarkers Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Renal Biomarkers Market Forecast: Breakup by Biomarker Type (in Million US$), 2022-2027
Table 3: Global: Renal Biomarkers Market Forecast: Breakup by Diagnostic Technique (in Million US$), 2022-2027
Table 4: Global: Renal Biomarkers Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Renal Biomarkers Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Renal Biomarkers Market: Competitive Structure
Table 7: Global: Renal Biomarkers Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Beckman Coulter Inc. (Danaher Corporation)
  • bioMérieux SA
  • BioPorto A/S
  • Bio-Rad Laboratories Inc.
  • Enzo Biochem Inc.
  • F. Hoffmann-La Roche AG
  • PerkinElmer Inc.
  • Randox Laboratories Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc

Methodology

Loading
LOADING...